DxTerity Earns SOC 2 Type 2 Compliance, Reinforcing Commitment to Secure Healthcare Data. Read more
 

IFN-1 Test for Lupus

WHITE PAPER

DxTerity® Type-1 Interferon Test for Risk Assessment

  • High IFN-1 levels increase the risks for lupus nephritis
  • Specific patient subgroups are at a greater risk for high IFN-1 and disease progression
  • IFN-1 status can serve as a prognostic indicator for disease activity and therapeutic response
img white paper 1 thumbnail

Better health management begins
at home

Subscribe to receive the latest information on new developments and products at DxTerity.